Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
Polycystic Ovary Syndrome, Infertility
About this trial
This is an interventional treatment trial for Polycystic Ovary Syndrome focused on measuring polycystic ovary syndrome, Infertility, Clomiphene citrate, Letrozole
Eligibility Criteria
Inclusion Criteria: Women age between 18-40 years. Normal husband semen analysis. Exclusion Criteria: All infertile couples who had other causes of infertility than PCOS. Those who had recently taken these medications. Any contraindication to use of drugs e.g renal or hepatic dysfunction, hypersensitivity to this drug. BMI>35 because obese women respond poorly to ovulation induction.
Sites / Locations
- Services Institute of Medical sciences
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
letrozole
Clomiphene citrate
Patients were given letrozole 2.5 mg-7.5mg per day for 5 days started from 2nd day of menses.
Patients were given clomiphene citrate 50-150mg per day for 5 days started from 2nd day of the menses.